StonvexLoading…
StonvexStonvexStonvexCore line items from DSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.33M | $20.76M | $16.63M | $10.24M |
Operating Income | $-5.49M | $-14.43M | $-10.38M | $-7.15M |
Net Income | $-5.82M | $-23.93M | $-10.09M | $-7.90M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $71.27M | $67.63M | $92.12M | $93.39M |
Total Liabilities | $58.72M | $58.91M | $66.02M | $66.02M |
Cash & Equivalents | $4.94M | $6.21M | $7.02M | $9.38M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-7.80M | $286.00K |
Shares Outstanding | 10.04M | 9.09M | 9.09M | 9.09M |